.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Julphar
Harvard Business School
Dow
Deloitte
Mallinckrodt
McKinsey
UBS
Medtronic
US Department of Justice

Generated: November 21, 2017

DrugPatentWatch Database Preview

CLONAZEPAM Drug Profile

« Back to Dashboard

Which patents cover Clonazepam, and when can generic versions of Clonazepam launch?

Clonazepam is a drug marketed by Teva, Sun Pharm Inds Inc, Sandoz, Mylan Pharms Inc, Accord Hlthcare, Mylan, Prinston Inc, Watson Labs, Apotex Inc, Actavis Elizabeth, Par Pharm, and Barr. and is included in fifteen NDAs.

The generic ingredient in CLONAZEPAM is clonazepam. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the clonazepam profile page.

Pharmacology for CLONAZEPAM

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

Medical Subject Heading (MeSH) Categories for CLONAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
CLONAZEPAM
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL077171-003Aug 3, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
CLONAZEPAM
clonazepam
TABLET;ORAL075468-003Oct 6, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
CLONAZEPAM
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL077194-003Aug 10, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
CLONAZEPAM
clonazepam
TABLET;ORAL074979-002Aug 29, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Barr
CLONAZEPAM
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL077194-004Aug 10, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
CLONAZEPAM
clonazepam
TABLET;ORAL074964-002Dec 30, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
CLONAZEPAM
clonazepam
TABLET;ORAL074869-001Oct 31, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
CLONAZEPAM
clonazepam
TABLET;ORAL074964-003Dec 30, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
CLONAZEPAM
clonazepam
TABLET;ORAL074920-001Aug 4, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
CLONAZEPAM
clonazepam
TABLET;ORAL075150-003Oct 5, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
Cerilliant
McKinsey
US Army
Cantor Fitzgerald
Mallinckrodt
Moodys
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot